CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis

Citation
O'Meara E, McDonald M, Chan M, et al. Can J Cardiol 2020;36:159–69.